Authors: Blackstock, AW

Citation: Aw. Blackstock, Radiation sensitizers, fractionation schedules, and future clinical trials, MD AND SOIL, 2002, pp. 301-310

Authors: Blackstock, AW Lightfoot, H Case, LD Tepper, JE Mukherji, SK Mitchell, BS Swarts, SG Hess, SM

Citation: Aw. Blackstock et al., Tumor uptake and elimination of 2 ',2 '-difluoro-2 '-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: Correlation with in vivo tumor response, CLIN CANC R, 7(10), 2001, pp. 3263-3268

Authors: Blackstock, AW Lesser, GJ Fletcher-Steede, J Case, LD Tucker, RW Russo, SM White, DR Miller, A

Citation: Aw. Blackstock et al., Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer, INT J RAD O, 51(5), 2001, pp. 1281-1289

Authors: Palermo, JA Richards, F Lohman, KK Lovelace, JV Atkinson, J Case, LD White, DR Blackstock, AW

Citation: Ja. Palermo et al., Phase II trial of adjuvant radiation and intraperitoneal 5-fluorouracil for locally advanced colon cancer: Results with 10-year follow-up, INT J RAD O, 47(3), 2000, pp. 725-733

Authors: Blackstock, AW Bernard, SA Richards, F Eagle, KS Case, LD Poole, ME Savage, PD Tepper, JE

Citation: Aw. Blackstock et al., Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer, J CL ONCOL, 17(7), 1999, pp. 2208-2212

Authors: Blackstock, AW Tepper, JE

Citation: Aw. Blackstock et Je. Tepper, Phase I trial dosing of gemcitabine and concurrent involved field irradiation in patients with localized pancreatic carcinomas - In Reply, J CL ONCOL, 17(11), 1999, pp. 3692-3692